EP2421888
CLEVER-1 Viðtaka mótlyf til að stöðva ónæmishindrandi átfrumur af gerð 2
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.4.2010EP published:
21.2.2018EP application number:
10766694.3
EP translation filed:
16.4.2018Grant published:
15.5.2018EPO information:
European Patent Register
Max expiry date:
5.4.2030Expiry date:
5.4.2026Next due date:
30.4.2026
Title:
CLEVER-1 Receptor Antagonists for blocking immune-inhibitory type 2 macrophages.
Timeline
Today
6.4.2010EP application
21.2.2018EP Publication
16.4.2018Translation submitted
15.5.2018Registration published
5.4.2026Expires
Owner
Name:
Faron Pharmaceuticals OYAddress:
Joukahaisenkatu 6, 20520, Turku, FI
Inventor
Name:
JALKANEN, SirpaAddress:
Piispanristi, FI
Name:
SALMI, MarkoAddress:
Turku, FI
Name:
JALKANEN, MarkkuAddress:
Piispanristi, FI
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
20090161Date:
22.4.2009Country:
FI
Classification
Categories:
A61K 38/17, A61K 38/20, A61K 31/58, A61K 35/15, C12Q 1/68, C12N 15/113, C12N 15/115, A61K 39/00, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 13.6.2018
Expires: 5.4.2019
Payer: Árnason Faktor
Number: 10
Paid: 24.4.2019
Expires: 5.4.2020
Payer: Árnason Faktor
Number: 11
Paid: 22.4.2020
Expires: 5.4.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 14.4.2021
Expires: 5.4.2022
Payer: CPA Global (Patrafee) AB
Number: 13
Paid: 20.4.2022
Expires: 5.4.2023
Payer: CPA Global (Patrafee) AB
Number: 14
Paid: 19.4.2023
Expires: 5.4.2024
Payer: CPA Global (Patrafee) AB
Number: 15
Paid: 19.4.2024
Expires: 5.4.2025
Payer: CPA Global (Patrafee) AB
Number: 16
Paid: 23.4.2025
Expires: 5.4.2026
Payer: CPA Global (Patrafee) AB